FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Positive Data with Imfinzi Regimen in Bladder Cancer

AstraZeneca reports positive data in a trial evaluating perioperative treatment with Imfinzi (durvalumab) combined with neoadjuvant enfortumab vedotin...

latest-news-card-1
Medical Devices

Petition Urges Actions Against Weight Loss Device

A citizen petition urges FDA to take enforcement action against the BariClip, an implantable bariatric device that petitioners say is being marketed a...

latest-news-card-1
Human Drugs

Add Warning to OTC Acetaminophen Product Labels: Petition

Americans for Scientific Integrity asks FDA to add reproductive development warnings and use instructions to labeling for over-the-counter acetaminoph...

latest-news-card-1
Human Drugs

FDA Issues Guide on Long-Acting Local Anesthetics

FDA posts a draft guidance outlining recommendations for drugmakers developing local anesthetic products designed to provide prolonged postoperative p...

latest-news-card-1
Human Drugs

AEMS May Mean Increased Stakeholder Scrutiny: Column

Three Morgan Lewis attorneys say companies regulated by FDA should prepare for increased scrutiny due to near-real-time data being available in the ag...

latest-news-card-1
Human Drugs

FDA Publishes 2 Analgesic Draft Guidances

FDA publishes draft guidances on developing non-opioid analgesics for chronic pain and facilitating a benefit/risk analysis for opioid analgesics.

latest-news-card-1
Marketing

Brukinsa TV Ad False or Misleading: OPDP

A CDER Office of Prescription Drug Promotion Notice of Violation cites a misleading BeOne Medicine TV spot for its leukemia drug Brukinsa.

latest-news-card-1
FDA General

Despite Makary Leaving, Industry Could Feel Pressure: Analysis

Analysts and investors interviewed by Reuters see a short-term positive reaction to the departure of Marty Makary, but caution that a prolonged leader...

latest-news-card-1
Human Drugs

Guidance Signals Broader Public Health Scrutiny for New Opioids

FDA releases a draft guidance detailing how the agency will evaluate the benefits and risks of new opioid analgesic drugs, emphasizing that approval d...

latest-news-card-1
FDA General

Inspection Pilot May be Permanent as FDA Expands AI-Driven Oversight

A King & Spalding legal analysis examines FDAs newly announced pilot program for one-day inspectional assessments, suggesting it may signal a long-ter...